4//SEC Filing
Kay Mark A 4
Accession 0001209191-21-042044
CIK 0001664106other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:39 PM ET
Size
5.6 KB
Accession
0001209191-21-042044
Insider Transaction Report
Form 4
Kay Mark A
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-18+5,000→ 5,000 totalExercise: $4.05Exp: 2031-06-18→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan in relation to the Reporting Person's service on the Issuer's Scientific Advisory Board. The options will vest over two years: 50% of the options will vest on the first anniversary of the grant date with the remaining 50% vesting on the second anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through each vesting date.
Documents
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001752537
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:39 PM ET
- Size
- 5.6 KB